About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Pancreatic Tumor Metastasis of the Tongue

prednisolon kur

prednisolon
Eda Kucuktulu, Uzer Kucuktulu1, Ali Guner1, H Bengu Cobanoglu2, Sevdegul Mungan3, Asuman Onal Mirik
From the Department of Radiation Oncology, General Surgery1, Ear Nose Throat Surgery2, Trabzon Kanuni Training and Research Hospital. Department of Pathology3, Karadeniz Technical University, Turkey.
Corresponding Author:
Prof. Uzer Kucuktulu
Email: kucuktulu@yahoo.com
Received: 30-JUL-2013 Accepted: 26-SEP-2013 Published Online: 30-OCT-2013
DOI: http://dx.doi.org/10.17659/01.2013.0089
Abstract
Distant metastasis to oral cavity is very rare and represents approximately 1% of all cases of neoplasm in oral cavity. Pancreatic cancers rarely metastasize to the oral cavity. Probably the highly aggressive nature of the pancreatic cancer does not give most of the patients a chance to live long enough to have an oral cavity metastasis. There is only a single case of pancreatic cancer with tongue metastasis reported in the literature. We presented a case of tongue metastasis of pancreatic cancer.
Keywords : Pancreas, Tongue Neoplasms, Pancreatic Neoplasms, Mouth.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024